References - Antibiotic Prescribing

  1. Joint Formulary Committee. British National Formulary, Edn. 61, London. British Medical Association and Royal Pharmaceutical Society of Great Britain (2011) (www.bnf.org)
  2. Paediatric Formulary Committee. BNF for Children, London. British Medical Association, Royal Pharmaceutical Society of Great Britain Royal College of Paediatrics and Child health, and Neonatal and Paediatric Pharmacists Group (2011) (www.bnf.org)
  3. Scottish Dental Clinical Effectiveness Programme. Drug Prescribing for Dentistry, Dental Clinical Guidance, 2nd Edn. (2011) (www.scottishdental.org/cep)
  4. Faculty of General Dental Practitioners (UK). Antimicrobial Prescribing for General Dental Practitioners, 2nd Edn. (2012) (www.fgdp.org.uk)
  5. Matthews D, Sutherland S. Clinical practice guidelines on emergency management of acure periapical periodontitis and apical abscess. Evid Based Dent 2004;5:7-11.( http://www.ncbi.nlm.nih.gov/pubmed/15448658)
  6. Martin MV, Longman LP, Hill JB, Hardy P. Acute dento-alveolar infections: an investigation of the duration of antibiotic therapy. Br Dent J 1997;183(4):135-7. (http://www.ncbi.nlm.nih.gov/pubmed/9293130)
  7. Brennan MT, Runyon MS, Batts JJ, Fox PC, Kent ML, Cox TL, et al. odontogenic signs and symptoms as predictors of odontogenic infection : a clinical trial. J Am Dent Assoc 2006;137(1):62-6 (http://www.ncbi.nlm.nih.gov/pubmed/16457000)
  8. Nagle D, reader A, Beck M, Weaver J. Effect of systemic penicillin in untreated irreversible pulpitis. Oral Surg Oral med Oral Pathol Oral Radiol Endod 2000;90(5):636-40. (http://www.ncbi.nlm.nih.gov/pubmed/11077389)
  9. Pickenpaugh L, Reader A, Beck M, Meyers WJ, Peterson LJ. Effect of prophylactic amoxicillin on endodontic flare-up in asymptomatic, necrotic teeth. J Endod 2001;27(1);53-6 (http://www.ncbi.nlm.nih.gov/pubmed/11487166)
  10. Henry M, Readre A, Beck M. Effect of penicillin on postoperative endodontic pain and swelling in symptomatic necrotic teeth. J Endod 2001; 27(2):117-23.( http://www.ncbi.nlm.nih.gov/pubmed/11491635)
  11. Faculty of Dental Surgery. National Clinical Guidelines 1997. London: The Royal College of Surgeons of England, 1997 (reviewed 2004)
  12. Matthews DC, Sutherland S, Basrani B. Emergency management of acute apical abscesses in the permanent dentition: a systematic review of the literature. J Can Dent Assoc 2003;69(10):660 (http://www.ncbi.nlm.nih.gov/pubmed/14611715)
  13. Habib G, Toen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30:2369 2413. (http://www.ncbi.nlm.nih.gov/pubmed/19713420)
  14. AHA 2007 guidelines for the prevention of infective endocarditis: Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: aguidelines from the American Heart Association, Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anaesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 20017; 116:1736. (http://circ.ahajournals.org/content/116/15/1736)
  15. Prophylaxis against infective endocarditis. National Institute for Health and Clinical Guidance, 2008. http://www.nice.org.uk/CG064

Skin Conditions

  1. Zouboulis C, Desai N, Emstetam L et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. JEADV 2015;29:619-644.
  2. White LC, Lanza S, Middleton J, Hewitt K, Freire-Moran L, Edge C, Nicholls M, Rajan-Iyer J, Cassell JA. The management of scabies outbreaks in residential care facilities for the elderly in England: a review of current health protection guidelines.Epidemiology and Infection.
  3. 2016 Nov 1:1-0. https://www.bashh.org/documents/Scabies_guidelines_DRAFT_2016.pdf.
  4. http://www.iusti.org/regions/europe/pdf/2010/Euro_Guideline_Scabies_2010.pdf.
  5. Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, Hay R, Steer A, members of the International Alliance for the Control of Scabies (IACS. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013 Aug 8;7(8):e2167
  6. https://www.cdc.gov/parasites/scabies/health_professionals/meds.html.
  7. Kreijkamp‐Kaspers  S, Hawke  K, Guo  L, Kerin  G, Bell‐Syer  SEM, Magin  P, Bell‐Syer  SV, van Driel  ML. Oral antifungal medication for toenail onychomycosis. Cochrane Database of Systematic Reviews 2017, Issue 7. Art. No.: CD010031. DOI: 10.1002/14651858.CD010031.pub2
  8. Ameen M et al. BAD guidelines for onychomycosis. BJD 2014; 171: 937–958
  9. Shemer A. Update : medical treatment of onychomycosis. Invited article. Dermatological therapy. 2012;25:582-593.
  10. Dalal  A, Eskin‐Schwartz  M, Mimouni  D, Ray  S, Days  W, Hodak  E, Leibovici  L, Paul  M. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD009758. DOI: 10.1002/14651858.CD009758.pub2

Updated September 2018